Novo participated in Menlo's series C round, which follows the completion of two clinical trials for the skin condition drug developer's lead product candidate.

Tasly Pharma has led a series E round for PegBio, which is working on drugs to treat diabetes and obesity, and which is also backed by Legend Holdings.

Medication Management Systems, a University of Minnesota spinout, has been acquired for an undisclosed sum.

The accelerator will focus on health and fitness technologies and is being support by Johns Hopkins University, University Maryland and others.

The research collaboration agreement is the largest ever such deal signed by Purdue University.

Chronic disease prevention platform Solera Health has now raised more than $30m in total, after raising funding from backers including Blue Cross Blue Shield Venture Partners.

Gencove has developed a genetic testing program that enables users to access services such as genome sequencing without requiring access to a lab themselves.

The vital signs tracker developer has raised $13.5m in an oversubscribed round that included corporates Swiss Re and STMicroelectronics.